Function of BMPs and BMP antagonists in adult bone

Annals of the New York Academy of Sciences

Volumn 1068, Issue 1, 2006, Pages 41-53

  Abe, Etsuko ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BMP; BMP antagonist; Bone remodeling; Catenin; Osteoblast; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR ANTAGONIST; CATENIN; CHORDIN; COLLAGEN; FOLLISTATIN; FRIZZLED PROTEIN; NOGGIN; OSTEOGENIC PROTEIN 1; PROTEIN; PROTEOGLYCAN; RECEPTOR BLOCKING AGENT; SCLEROSTIN; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

BONE; BONE DENSITY; BONE REMODELING; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; EMBRYO DEVELOPMENT; GASTRULATION; GENE DELETION; GENE MUTATION; GENETIC TRANSCRIPTION; GROWTH RETARDATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LETHALITY; LIMB DEVELOPMENT; LUNG; MESENCHYME CELL; NEURAL CREST; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOSARCOMA; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; SPLEEN; THYMUS; TRANSGENIC MOUSE; XENOPUS;

MUS MUSCULUS;

EID: 33744772589     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1346.007     Document Type: Conference Paper

References (60)

1. Wozney, J.M. 1993. Bone morphogenetic proteins and their gene expression. In Cellular and Molecular Biology of Bone. M. Noda, Ed. : 131 167. Academic Press. San Diego, CA.
2. Botchkarev, V. & A.A. Sharov. 2004. BMP signaling in the control of skin development and hair follicle growth. Differentiation 72 : 512 526.
3. Needham, S.J., M. Brittan, S.A. McDonald, et al. 2005. Intestinal stem cells. J. Cell Mol. Med. 9 : 11 24.
4. Kishigami, S. & Y. Mishina. 2005. BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev. 16 : 265 278.
5. Tsumaki, N. & H. Yoshikawa. 2005. The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev. 16 : 279 285.
6. Kugimiya, F., H. Kawaguchi, S. Kamekura, et al. 2005. Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J. Biol. Chem. 280 : 35704 35712.
7. Gazzerro, E., V. Gangji & E. Canalis. 1998. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 10 : 2106 2114.
8. Abe E, M. Yamamoto, Y. Taguchi, et al. 2000. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J. Bone Miner. Res. 15 : 663 673.
9. Moon, R.T., A.D., Kohn, G.V. DeFerrari, et al. 2004. Wnt and β-catenin signaling: diseases and therapies. Nature Rev. Genet. 5 : 689 699.
10. Miyazono, K., S. Maeda & T. Imamura. 2005. BMP receptor signaling: transcriptional targets, regulation of signals and signaling cross-talk. Cytokine Growth Factor Rev. 16 : 251 263.
11. Nohe, A., E. Keating, P. Knaus, et al. 2004. Signal transduction of bone morphogenetic protein receptors. Cell. Signal. 16 : 291 299.
12. Chen, D.I., M. Zhao & G.R. Mundy. 2004. Bone morphogenetic proteins. Growth Factors 22 : 233 241.
13. Hullinger, T.G., Q. Pan, H. Viswanathan, et al. 2001. TGFbeta and BMP2 activation of the OPN promoter: roles of smad-and hox-binding elements. Exp. Cell Res. 262 : 69 74.
14. Wan, M., X. Shi, X. Feng, et al. 2001. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects. J. Biol. Chem. 276 : 36241 36250.
15. Stopa, M., D. Anhuf, L. Trestegen, et al. 2000. Participation of smad2, smad3, and smad4 in transforming growth factor beta (TGF-beta) induced activation of smad7. J. Biol. Chem. 275 : 29308 29317.
16. Guicheux, J., J. Lemonnier, C. Ghayor, et al. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 18 : 2060 2068.
17. Osyczka, A.M. & P.S. Leboy. 2005. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146 : 3428 3437.
18. Zimmerman, L.B., J.M. De Jesus-Escobar & R.M. Harland. 1996. The Spemann organizer signal, noggin, binds and inactivates bone morphogenetic protein 4. Cell 86 : 599 606.
19. Larrain, J., D. Bachiller, B. Lu, et al. 2000. BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development 127 : 821 830.
20. Canalis, E., A. Economides & E. Gazzerro. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 24 : 218 235.
21. Yanagita, M. 2005. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev. 16 : 309 317.
22. Kuriyama, S., G. Lupo, K. Ohta, et al. 2006. Tsukushi controls ectodermal patterning and neural crest specification in Xenopus by direct regulation of BMP4 and X-delta-1 activity. Development 133 : 75 88.
23. Brunet, L.J., J.A. McMahon, A.P. McMahon, et al. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280 : 1455 1457.
24. Gong, Y., D. Krakow, J. Marcelino et al., 1999. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat. Genet. 21 : 302 304.
25. Gazzerro, E., V. Gangji & E. Canalis. 1998. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 10 : 2106 2114.
26. Wu, X.B., Y. Li, A. Schneider, et al. 2003. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin. Invest. 112 : 924 934.
27. Nakase, T., S. Nomura, H. Yoshikawa, et al. 1994. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J. Bone Miner. Res. 9 : 651 659.
28. Kloen, P., M. Di Paola, O. Borens, et al. 2003. BMP signaling components are expressed in human fracture callus. Bone 33 : 362 371.
29. Devlin, R.D., Z. Du, R.C. Pereira, et al. 2003. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 144 : 1972 1978.
30. Bachiller, D., J. Klingensmith, N. Shneyder, et al. 2003. The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 130 : 3567 3578.
31. Zhang, D., C.M. Ferguson, R.J. O'Keefe, et al. 2002. A role for the BMP antagonist chordin in endochondral ossification. J. Bone Miner. Res. 17 : 293 300.
32. Anderson, R.M., A.R. Lawrence, R.W. Stottmann, et al. 2002. Chordin and noggin promote organizing centers of forebrain development in the mouse. Development 129 : 4975 4987.
33. Gazzerro, E., V. Deregowski, S. Vaira, et al. 2005. Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro. Endocrinology 146 : 3875 3882.
34. Nosaka. T., S. Morita, H. Kitamura, et al. 2003. Mammalian twisted gastrulation is essential for skeleto-lymphogenesis. Mol. Cell Biol. 23 : 2969 2980.
35. Staehling-Hampton, K., S. Proll, B.W. Paeper, et al. 2002. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am. J. Med. Genet. 110 : 144 152.
36. Kasu, N., J. Laurikkala, M. Imanishi, et al. 2003. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein with unique ligand specificity. J. Biol. Chem. 278 : 24113 24117.
37. Winkler, D., M.K. Sutherl, J. Geoghegan, et al. 2003. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22 : 6267 6276.
38. van Bezooijen, R.L., B.A.J. Roelen, A. Visser, et al. 2004. Sclerostin is an osteocyte negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199 : 805 814.
39. Li, X., Y. Zhang, H. Kang, et al. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280 : 19883 19887.
40. Jilka, R.L., R.S. Weinstein, K. Takahashi, et al. 1996. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97 : 1732 1740.
41. Silva, M.J., M.D. Brodt & B.A. Uthgenannt. 2004. Morphological and mechanical properties of caudal vertebrae in the SAMP6 mouse model of senile osteoporosis. Bone 35 : 425 431.
42. Kaplan, F.S. & E.M. Shore. 2000. Progressive osseous heteroplasia. J Bone Miner Res. 15 : 2084 2094.
43. Kan L., M. Hu, WA. Gomes, et al. 2004. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am. J. Pathol. 165 : 1107 1115.
44. Zhao, M., S.E. Harris, D. Horn, et al. 2002. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J. Cell Biol. 157 : 1049 1060.
45. Yamashita, M., Y. Sai-Xia, Z. Gen-mu, et al. 2005. Ubiquitin ligase smurf1 control osteoblast activity and bone homeostases by targeting MEKK2 for degradation. Cell 121 : 101 113.
46. Mishina, Y., M.W. Starbuck, M.A. Gentile, et al. 2004. Bone morphogenetic protein 1A receptor signaling regulates postnatal osteoblast function and bone remodeling. J. Biol. Chem. 279 : 27560 27566.
47. Liu, Z., W. Shi, X. Ji, et al. 2004. Molecules mimicking smad1 interacting with Hox stimulate bone formation. J. Biol. Chem. 279 : 11313 11319.
48. Oshima, T., M. Abe, J. Asano, et al. 2005. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood. 106 : 3160 3165.
49. Hoang, B.H., T. Kubo, J.H. Healey, et al. 2004. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int. J. Cancer 109 : 106 111.
50. Etheridge, S.L., G.J. Spencer, D.J. Heath, et al. 2004. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22 : 849 860.
51. Bilic-Curcic, I., M. Kronenberg, X. Jiang, et al. 2005. Visualizing levels of osteoblast differentiation by a two-color promoter-GFP strategy: type I collagen-GFPcyan and osteocalcin-GFPtpz. Genesis 43 : 87 98.
52. Haegel, H., L. Larue, M. Ohsugi, et al. 1995. Lack of beta-catenin affects mouse development at gastrulation. Development 121 : 3529 3537.
53. Kato, M., M.S. Patel, R. Levasseur, et al. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157 : 303 314.
54. Bodine, P.V., W. Zhao, Y.P. Kharode, et al. 2004. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18 : 1222 1237.
55. Glass, D.A. II., P. Bialek, J.D. Ahn, et al. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8 : 751 764.
56. Hill, T.P., D. Spater, M.M. Taketo, et al. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8 : 727 738.
57. Gaur, T., C.J. Lengner, H. Hovhannisyan, et al. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280 : 33132 33140.
58. Rawadi, G., B. Vayssiere, F. Dunn, et al. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Miner. Res. 18 : 1842 1853.
59. Mbalaviele, G., S. Sheikh, J.P. Stains, et al. 2005. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell. Biochem. 94 : 403 418.
60. Mukhopadhyay, M., S. Shtrom, C. Rodriguez-Esteban, et al. 2001. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell 1 : 423 434.